Sami Corwin
Stock Analyst at William Blair
(n/a)
# 4,321
Out of 4,670 analysts
6
Total ratings
n/a
Success rate
-39.29%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sami Corwin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNYA Tenaya Therapeutics | Initiates: Outperform | n/a | $2.38 | - | 1 | Jun 10, 2024 | |
| NGNE Neurogene | Initiates: Outperform | n/a | $20.30 | - | 1 | Mar 21, 2024 | |
| MESO Mesoblast | Downgrades: Market Perform | n/a | $10.11 | - | 1 | Aug 4, 2023 | |
| CRSP CRISPR Therapeutics AG | Reinstates: Outperform | $75 | $47.88 | +56.64% | 1 | May 30, 2023 | |
| LEGN Legend Biotech | Initiates: Market Perform | n/a | $40.94 | - | 1 | May 25, 2023 | |
| QURE uniQure | Initiates: Outperform | $66 | $5.78 | +1,041.87% | 1 | Oct 27, 2021 |
Tenaya Therapeutics
Jun 10, 2024
Initiates: Outperform
Price Target: n/a
Current: $2.38
Upside: -
Neurogene
Mar 21, 2024
Initiates: Outperform
Price Target: n/a
Current: $20.30
Upside: -
Mesoblast
Aug 4, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $10.11
Upside: -
CRISPR Therapeutics AG
May 30, 2023
Reinstates: Outperform
Price Target: $75
Current: $47.88
Upside: +56.64%
Legend Biotech
May 25, 2023
Initiates: Market Perform
Price Target: n/a
Current: $40.94
Upside: -
uniQure
Oct 27, 2021
Initiates: Outperform
Price Target: $66
Current: $5.78
Upside: +1,041.87%